Lucid Diagnostics Inc.
LUCD
$1.26
-$0.03-2.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -30.83% | 2.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -30.83% | 2.13% | |||
| Cost of Revenue | -27.69% | 27.38% | |||
| Gross Profit | 23.73% | -85.16% | |||
| SG&A Expenses | 5.99% | 2.57% | |||
| Depreciation & Amortization | -106.31% | 111.43% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.17% | 4.72% | |||
| Operating Income | -1.72% | -4.98% | |||
| Income Before Tax | -133.15% | 6.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -133.15% | 6.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -133.15% | 6.71% | |||
| EBIT | -1.72% | -4.98% | |||
| EBITDA | -1.76% | -5.01% | |||
| EPS Basic | -164.80% | 19.50% | |||
| Normalized Basic EPS | -40.77% | 44.34% | |||
| EPS Diluted | -164.80% | 19.50% | |||
| Normalized Diluted EPS | -40.77% | 44.34% | |||
| Average Basic Shares Outstanding | 17.85% | 15.89% | |||
| Average Diluted Shares Outstanding | 17.85% | 15.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||